821 related articles for article (PubMed ID: 22530565)
21. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
[TBL] [Abstract][Full Text] [Related]
22. [Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin].
Henrion J; Libon E; De Maeght S; Deltenre P; Schapira M; Ghilain JM; Maisin JM; Heller FR
Gastroenterol Clin Biol; 2003 May; 27(5):534-9. PubMed ID: 12843918
[TBL] [Abstract][Full Text] [Related]
23. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit.
Bell H; Jahnsen J; Kittang E; Raknerud N; Sandvik L
Scand J Gastroenterol; 2004 Sep; 39(9):858-63. PubMed ID: 15513384
[TBL] [Abstract][Full Text] [Related]
24. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
[TBL] [Abstract][Full Text] [Related]
25. Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study.
Castells A; Saló J; Planas R; Quer JC; Ginès A; Boix J; Ginès P; Gassull MA; Terés J; Arroyo V
Hepatology; 1994 Sep; 20(3):584-91. PubMed ID: 8076916
[TBL] [Abstract][Full Text] [Related]
26. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).
Poynard T; Vergniol J; Ngo Y; Foucher J; Munteanu M; Merrouche W; Colombo M; Thibault V; Schiff E; Brass CA; Albrecht JK; Rudler M; Deckmyn O; Lebray P; Thabut D; Ratziu V; de Ledinghen V; ; ;
J Hepatol; 2014 Apr; 60(4):706-14. PubMed ID: 24291240
[TBL] [Abstract][Full Text] [Related]
27. Complications of cirrhosis.
Dong MH; Saab S
Dis Mon; 2008 Jul; 54(7):445-56. PubMed ID: 18570914
[No Abstract] [Full Text] [Related]
28. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
[TBL] [Abstract][Full Text] [Related]
29. Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis.
Das K; Das K; Datta S; Pal S; Hembram JR; Dhali GK; Santra A; Chowdhury A
Liver Int; 2010 Aug; 30(7):1033-42. PubMed ID: 20492502
[TBL] [Abstract][Full Text] [Related]
30. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients.
D'Amico G; Pasta L; Morabito A; D'Amico M; Caltagirone M; Malizia G; Tinè F; Giannuoli G; Traina M; Vizzini G; Politi F; Luca A; Virdone R; Licata A; Pagliaro L
Aliment Pharmacol Ther; 2014 May; 39(10):1180-93. PubMed ID: 24654740
[TBL] [Abstract][Full Text] [Related]
31. Outcome of chronic delta hepatitis in Italy: a long-term cohort study.
Niro GA; Smedile A; Ippolito AM; Ciancio A; Fontana R; Olivero A; Valvano MR; Abate ML; Gioffreda D; Caviglia GP; Rizzetto M; Andriulli A
J Hepatol; 2010 Nov; 53(5):834-40. PubMed ID: 20800919
[TBL] [Abstract][Full Text] [Related]
32. Management of patients with complications of cirrhosis.
Fowler C
Nurse Pract; 2013 Apr; 38(4):14-21; quiz 22-3. PubMed ID: 23454902
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and Management of Cirrhosis and Its Complications: A Review.
Tapper EB; Parikh ND
JAMA; 2023 May; 329(18):1589-1602. PubMed ID: 37159031
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for infections in cirrhotic patients with and without hepatocellular carcinoma.
Yoneyama K; Miyagishi K; Kiuchi Y; Shibata M; Mitamura K
J Gastroenterol; 2002; 37(12):1028-34. PubMed ID: 12522534
[TBL] [Abstract][Full Text] [Related]
35. Determinants of outcome of compensated hepatitis C virus-related cirrhosis.
Serfaty L; Aumaître H; Chazouillères O; Bonnand AM; Rosmorduc O; Poupon RE; Poupon R
Hepatology; 1998 May; 27(5):1435-40. PubMed ID: 9581703
[TBL] [Abstract][Full Text] [Related]
36. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
37. [Alcoholic fatty liver, alcoholic hepatitis and alcoholic cirrhosis. Drinking behavior and incidence of clinical, clinico-chemical and histological findings in 282 patients].
Bode JC; Kruse G; Mexas P; Martini GA
Dtsch Med Wochenschr; 1984 Oct; 109(40):1516-21. PubMed ID: 6236965
[TBL] [Abstract][Full Text] [Related]
38. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
[TBL] [Abstract][Full Text] [Related]
39. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
[TBL] [Abstract][Full Text] [Related]
40. Ten years of hospital admissions for liver cirrhosis in Portugal.
Silva MJ; Rosa MV; Nogueira PJ; Calinas F
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1320-6. PubMed ID: 26275086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
